## Vitamin D-Dependent Rickets: Type 1 vs Type 2 ### Pathophysiological Distinction VDDR-1 and VDDR-2 are both autosomal recessive disorders of vitamin D metabolism, but they differ fundamentally in the **site and nature of the enzymatic defect**. **Key Point:** VDDR-1 is a defect in **1α-hydroxylase** (conversion of 25-OH vitamin D → 1,25-(OH)~2~ vitamin D), while VDDR-2 is a defect in **vitamin D receptor (VDR)** function. ### Biochemical Comparison | Parameter | VDDR-1 (1α-Hydroxylase Deficiency) | VDDR-2 (VDR Defect) | |-----------|--------------------------------------|---------------------| | **25-OH vitamin D** | Low to normal (8–28 ng/mL) | Normal to elevated (>30 ng/mL) | | **1,25-(OH)~2~ vitamin D** | **LOW (8–15 pg/mL)** | **VERY HIGH (>200 pg/mL)** | | **Mechanism** | Impaired activation of vitamin D | Normal activation but target organ resistance | | **PTH response** | Responds to calcitriol (active vitamin D) | Does NOT respond (receptor defect) | | **Serum calcium** | Hypocalcemia | Hypocalcemia | | **Serum phosphate** | Hypophosphatemia | Hypophosphatemia | ### Clinical Correlations **High-Yield:** The **1,25-(OH)~2~ vitamin D level is the single best discriminator**: - **VDDR-1:** Low 1,25-(OH)~2~ vitamin D (kidney cannot activate vitamin D) → responds to **calcitriol therapy** - **VDDR-2:** Markedly elevated 1,25-(OH)~2~ vitamin D (kidney produces it, but target tissues are resistant) → **does NOT respond to calcitriol** **Mnemonic:** **VDDR-1 = Kidney defect (Low active form) → Calcitriol works**; **VDDR-2 = Receptor defect (High active form, no response) → Calcitriol fails** ### Pathophysiological Logic ```mermaid flowchart TD A[Vitamin D Deficiency or Defect]:::outcome --> B{Where is the problem?}:::decision B -->|Kidney activation| C[VDDR-1: 1α-hydroxylase defect]:::outcome B -->|Target tissue response| D[VDDR-2: VDR defect]:::outcome C --> E[Low 1,25-OH-D<br/>Normal/Low 25-OH-D]:::outcome D --> F[HIGH 1,25-OH-D<br/>Normal 25-OH-D]:::outcome E --> G[Responds to calcitriol]:::action F --> H[Resistant to calcitriol]:::urgent ``` **Clinical Pearl:** VDDR-2 patients may present with **alopecia** (hair loss) and **severe hypocalcemia refractory to treatment**, reflecting the systemic VDR dysfunction beyond bone. [cite:Harrison 21e Ch 405] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.